Pepcid and Ambisome drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Ambisome (amphotericin b). Common drug interactions include headache among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Ambisome. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Ambisome?

Ambisome has active ingredients of amphotericin b. eHealthMe is studying from 7,934 Ambisome users. Check the latest studies of Ambisome.



On Jul, 12, 2026

48 people who take Pepcid and Ambisome together, and have interactions are studied.

Pepcid and Ambisome drug interactions.

What are the common drug interactions of Pepcid and Ambisome, by gender? *:

female:

  1. Headache (pain in head)
  2. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  3. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  4. Pyrexia (fever)
  5. Respiratory disorder (respiratory disease)
  6. Abdominal discomfort
  7. Abdominal distension
  8. Acute respiratory distress syndrome
  9. Agitation (state of anxiety or nervous excitement)
  10. Anxiety

male:

  1. Blood creatinine increased
  2. Pyrexia (fever)
  3. Respiratory distress (difficulty in breathing)
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Abdominal distension
  7. Budd chiari syndrome (problem that results from blood clotting in the veins flowing out of the liver (hepatic veins))
  8. Death
  9. Electrolyte imbalance
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

What are the common drug interactions of Pepcid and Ambisome, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal infection
  2. Activated partial thromboplastin time prolonged
  3. Alanine aminotransferase increased
  4. Ammonia decreased
  5. Anaemia (lack of blood)
  6. Anion gap increased
  7. Aspartate aminotransferase increased
  8. Blast cell count increased
  9. Blood albumin decreased
  10. Blood calcium decreased

2-9:

n/a

10-19:

  1. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  2. Pancreatitis (inflammation of pancreas)
  3. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
  4. Respiratory distress (difficulty in breathing)

20-29:

  1. Abdominal distension
  2. Bacterial infection
  3. Blood creatinine increased
  4. Conjunctivitis (pink eye)
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. Oedema peripheral (superficial swelling)
  8. Pneumonia
  9. Pyrexia (fever)
  10. Respiratory distress (difficulty in breathing)

30-39:

  1. Cardiac failure congestive
  2. Death
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Multi-organ failure (multisystem organ failure)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Neoplasm progression (growth of tumour)
  8. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  9. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  10. Cryptococcosis (potentially fatal fungal disease)

40-49:

  1. Therapeutic response decreased (less preventive response)
  2. Vomiting
  3. Purpura (purplish discoloration of the skin)
  4. Nausea (feeling of having an urge to vomit)
  5. Platelet count decreased
  6. Aspergillosis (an infection caused by a fungus called aspergillus)
  7. Cytomegalovirus colitis (an inflammation of the colon from virus)
  8. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  9. Diarrhoea
  10. General physical health deterioration (weak health status)

50-59:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood bilirubin increased
  4. Blood lactate dehydrogenase increased
  5. Atrioventricular block second degree (heart block second degree)
  6. Budd chiari syndrome (problem that results from blood clotting in the veins flowing out of the liver (hepatic veins))
  7. Electrolyte imbalance
  8. Encephalopathy (functioning of the brain is affected by some agent or condition)
  9. Hepatorenal failure (decrease in kidney function in a person with a severe liver disorder)
  10. Respiratory alkalosis (elevated blood ph due to excess breathing)

60+:

  1. Diarrhoea
  2. Pyrexia (fever)
  3. Sinusitis (inflammation of sinus)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Abdominal distension
  6. Abdominal pain
  7. Alanine aminotransferase increased
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Blood bilirubin increased
  10. Blood culture positive

What are the existing conditions these people have? *

  1. Gastritis (inflammation of stomach): 7 people, 14.58%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 7 people, 14.58%
  3. Pneumonia Legionella (pneumonia caused by the bacteria legionella): 6 people, 12.50%
  4. Nausea (feeling of having an urge to vomit): 3 people, 6.25%
  5. Multiple Myeloma (cancer of the plasma cells): 3 people, 6.25%
  6. Fungal Infection: 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Ambisome?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid and Ambisome:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ambisome:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambisome and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and amphotericin b (the active ingredients of Pepcid and Ambisome, respectively), and Pepcid and Ambisome (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: